Duration: 20 minutes

The development of three-dimensional (3D) models for drug development and disease modelling is associated with numerous challenges. Conventional methods for 3D model generation can be time consuming, resource intensive, and generate inconsistent results. Automated technologies can help to streamline complex processes to enable savings in both time and resources, while improving the robustness and consistency of workflows. 

The data presented in this talk showcases an automated process for the generation of iPSC spheroids from a single cell, resulting in the generation of a monoclonal 3D spheroid structure. Engineering monoclonal iPSC spheroids presents an opportunity to tailor models to specific diseases or conditions and provides insight into the development of 3D structures by using fluorescently labelled cell populations. 

Explore a robust workflow beginning with single cell iPSCs through to monoclonal iPSC spheroids using live cell monitoring and endpoint phenotyping analysis in this on-demand webinar.

Looking for tailored support to access more opportunities like this? IncluScief offers personalized opportunity identification and strategic advisory services to help you or your organization succeed. Contact us today at  info@incluscief.org to learn how we can help you unlock new possibilities and achieve your goals.